Inhibition of Toxoplasma gondii by indirubin and tryptanthrin analogs

Antimicrobial Agents and Chemotherapy

Volumn 52, Issue 12, 2008, Pages 4466-4469

  Krivogorsky, Bogdana ^a   Grundt, Peter ^b   Yolken, Robert ^a   Jones Brando, Lorraine ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MINNESOTA DULUTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIPROTOZOAL AGENT; INDIRUBIN; TRYPTANTHRIN DERIVATIVE; UNCLASSIFIED DRUG;

ANTIPROTOZOAL ACTIVITY; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFICACY; DRUG INHIBITION; HUMAN; HUMAN CELL; ISATIS; PRIORITY JOURNAL; TOXOPLASMA GONDII; TOXOPLASMOSIS;

ANIMALS; ANTIPROTOZOAL AGENTS; DRUGS, CHINESE HERBAL; INDOLES; ISATIS; PARASITIC SENSITIVITY TESTS; QUINAZOLINES; TOXOPLASMA;

EID: 57049167732     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.00903-08     Document Type: Article

References (12)

1. Beauchard, A., Y. Ferandin, S. Frere, O. Lozach, M. Blairvacq, L. Meijer, V. Thiery, and T. Besson. 2006. Synthesis of novel 5-substituted indirubins as protein kinases inhibitors. Bioorg. Med. Chem. 14:6434-6443.
2. Bhattacharjee, A. K., M. G. Hartell, D. A. Nichols, R. P. Hicks, B. Stanton, J. E. van Hamont, and W. K. Milhous. 2004. Structure-activity relationship study of antimalarial indolo[2,1-b]quinazoline-6,12-diones (tryptanthrins). Three dimensional pharmacophore modeling and identification of new antimalarial candidates. Eur. J. Med. Chem. 39:59-67.
3. Bhattacharjee, A. K., D. J. Skanchy, B. Jennings, T. H. Hudson, J. J. Brendle, and K. A. Werbovetz. 2002. Analysis of stereoelectronic properties, mechanism of action and pharmacophore of synthetic indolo[2,1-b]quinazoline-6, 12-dione derivatives in relation to antileishmanial activity using quantum chemical, cyclic voltammetry and 3-D-QSAR CATALYST procedures. Bioorg. Med. Chem. 10:1979-1989.
4. Grant, K. M., M. H. Dunion, V. Yardley, A. L. Skaltsounis, D. Marko, G. Eisenbrand, S. L. Croft, L. Meijer, and J. C. Mottram. 2004. Inhibitors of Leishmania mexicana CRK3 cyclin-dependent kinase: chemical library screen and antileishmanial activity. Antimicrob. Agents Chemother. 48:3033-3042.
5. Jones-Brando, L., E. F. Torrey, and R. Yolken. 2003. Drugs used in the treatment of schizophrenia and bipolar disorder inhibit the replication of Toxoplasma gondii. Schizophr. Res. 62:237-244.
6. Khan, F., J. Z. Tang, C. L. Qin, and K. Kim. 2002. Cyclin-dependent kinase TPK2 is a critical cell cycle regulator in Toxoplasma gondii. Mol. Microbiol. 45:321-332.
7. Liau, B. C., T. T. Jong, M. R. Lee, and S. S. Chen. 2007. LC-APCI-MS method for detection and analysis of tryptanthrin, indigo, and indirubin in Daqingye and Banlangen. J. Pharm. Biomed. Anal. 43:346-351.
8. Lipinski, C. A., F. Lombardo, B. W. Dominy, and P. J. Feeney. 1997. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv. Drug Deliv. Rev. 23: 3-25.
9. Nam, S., R. Buettner, J. Turkson, D. Kim, J. Q. Cheng, S. Muehlbeyer, F. Hippe, S. Vatter, K. H. Merz, G. Eisenbrand, and R. Jove. 2005. Indirubin derivatives inhibit Stat3 signaling and induce apoptosis in human cancer cells. Proc. Natl. Acad. Sci. USA 102:5998-6003.
10. Reed, L. J., and H. Muench. 1938. A simple method of estimating fifty percent endpoints. Am. J. Hyg. 27:493-499.
11. Scovill, J., E. Blank, M. Konnick, E. Nenortas, and T. Shapiro. 2002. Anti-trypanosomal activities of tryptanthrins. Antimicrob. Agents Chemother. 46:882-883.
12. Sharma, V. M., P. Prasanna, K. V. Adi Seshu, B. Renuka, C. V. Laxman Rao, G. Sunil Kumar, C. P. Narasimhulu, P. Aravind Babu, R. C. Puranik, D. Subramanyam, A. Venkateswarlu, S. Rajagopal, K. B. S. Kumar, C. S. Rao, N. V. S. R. Mamidi, D. S. Deevi, R. Ajaykumar, and R. Rajagopalan. 2002. Novel indolo[2,1-b]quinazoline analogues as cytostatic agents: synthesis, biological evaluation and structure-activity relationship. Bioorg. Med. Chem. Lett. 12:2303-2307.